查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1810892

2025年酵素免疫分析法全球市场报告

Enzyme Immunoassay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年酵素免疫分析法市场规模将强劲成长，到2029年将达到283.7亿美元，复合年增长率为7.2%。预测期内的增长可归因于政府和非政府组织主导的疾病控制倡议、自体免疫疾病检测的兴起、就地检验的普及、肿瘤伴随诊断需求的不断增长以及老年人口的增长。预计在此期间的主要趋势包括微孔盘读数仪和试剂的技术进步、创新诊断技术的采用、环保试剂的开发、人工智慧和自动化技术与免疫检测流程的整合，以及策略联盟和伙伴关係关係的增加。

感染疾病的日益流行预计将推动酵素免疫分析法市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等有害微生物引起的疾病，可以在人与人之间传播。抗生素抗药性的上升加重了这些疾病的负担，导致治疗更加复杂、恢復时间更长、医疗成本更高、死亡率更高。酵素免疫分析法是诊断感染疾病的重要工具，能够高灵敏度和特异性检测患者样本中的抗原和抗体。这有助于早期诊断、有效监测和及时治疗爱滋病毒、肝炎和流感等疾病。例如，2025 年 4 月，美国政府机构明尼苏达州卫生部报告称，35 至 39 岁男性爱滋病毒感染者比例从 2023 年的 10% 上升到 2024 年的 17%。因此，感染疾病负担的增加促进了酵素免疫分析法市场的扩张。

酵素免疫分析法市场的主要企业正在优先开发先进的解决方案，例如全自动酵素免疫分析法，以提高诊断准确性，减少人为错误并简化临床实验室工作流程。自动化酵素免疫分析法简化了整个测试过程，提高了实验室诊断的速度、准确性和可靠性。例如，日本体外诊断製药公司FUJIREBIO Holdings Inc. 于 2024 年 7 月推出仅供研究使用 (RUO) 的全自动 Lumipulse G GFAP 检测，扩大了其神经生物标记产品线。这种化学冷光酵素免疫分析法使用 Lumipulse G 平台测量人类血浆和血清中的神经胶质纤维酸性蛋白 (GFAP) 水平，可在 35 分钟内提供结果。 GFAP 是一种与多发性硬化症、阿兹海默症、帕金森氏症、中风和创伤性脑损伤等神经系统疾病相关的星状细胞生物标记。这种新的检测方法补充了FUJIREBIO的神经退化性疾病产品组合，该组合已经包括 NfL、pTau217 和 sTREM2 等标记，支援在单一自动化平台上进行全面分析。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球酵素免疫分析法：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球酵素免疫分析法市场：成长率分析
  • 全球酵素免疫分析法市场表现：规模与成长，2019-2024
  • 全球酵素免疫分析法市场预测：规模与成长，2024-2029，2034
  • 全球酵素免疫分析法：总潜在市场（TAM）

第六章 市场细分

  • 全球酵素免疫分析法市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 试剂和套件
  • 分析设备或装置
  • 软体和服务
  • 全球酵素免疫分析法市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 唾液
  • 尿
  • 其他样品
  • 全球酵素免疫分析法市场的应用、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗监测
  • 肿瘤学
  • 心臟病学
  • 内分泌学
  • 传染病检查
  • 自体免疫疾病
  • 其他的
  • 全球酵素免疫分析法市场最终用途、效能及预测（2019-2024、2024-2029、2034）
  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 学术研究中心
  • 其他的
  • 全球酵素免疫分析法市场：试剂和套件细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 抗体
  • 抗原
  • 基材
  • 缓衝剂和稳定剂
  • 全球酵素免疫分析法市场：分析仪器或设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 全自动EIA分析仪
  • 半自动环评系统
  • 微孔盘读数仪
  • 洗衣机和培养箱
  • 全球酵素免疫分析法市场：软体与服务细分、类型、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 数据分析与解释软体
  • 实验室资讯系统整合工具
  • 设备校准和检验服务
  • 技术支援和使用者培训

第七章 区域和国家分析

  • 全球酵素免疫分析法市场：依地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球酵素免疫分析法市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 酵素免疫分析法市场：竞争格局
  • 酵素免疫分析法市场：公司简介
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories Inc.
    • Danaher Corporation
    • Merck KGaA

第31章：其他领先和创新企业

  • Siemens Healthineers AG
  • Becton Dickinson and Company（BD）
  • PerkinElmer Inc.
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Diasorin SpA
  • Bio-Techne Corporation
  • Quidel Corporation
  • Promega Corporation
  • Abcam plc
  • BioLegend Inc.
  • Helena Laboratories Corporation
  • Cayman Chemical Company
  • Enzo Life Sciences Inc.
  • RayBIoTech Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年酵素免疫分析法市场：提供新机会的国家
  • 2029 年酵素免疫分析法市场：细分市场将带来新机会
  • 2029年酵素免疫分析法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r36992

Enzyme immunoassay is a highly sensitive laboratory technique that utilizes antibodies conjugated with enzymes to specifically identify and quantify target molecules such as proteins, hormones, or infectious agents within a sample. The method is based on an enzymatic reaction that generates a detectable signal-often a color change-which correlates directly with the concentration of the analyte, enabling accurate diagnostic or research analysis.

The primary product types in enzyme immunoassay include reagents and kits, analyzers or instruments, and software and services. Reagents and kits consist of chemical substances or pre-packaged sets of chemicals used in laboratory and clinical testing to detect, measure, or process other substances. These products accommodate various specimen types, such as blood, saliva, urine, and others, and support a wide array of applications, including therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease detection, autoimmune disease testing, and more. They serve a broad range of end users, including hospitals, blood banks, clinical laboratories, pharmaceutical and biotechnology companies, academic research centers, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The enzyme immunoassay market research report is one of a series of new reports from The Business Research Company that provides enzyme immunoassay market statistics, including enzyme immunoassay industry global market size, regional shares, competitors with an enzyme immunoassay market share, detailed enzyme immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme immunoassay industry. This enzyme immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enzyme immunoassay market size has grown strongly in recent years. It will grow from $20.01 billion in 2024 to $21.50 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to the increasing prevalence of infectious diseases, the expansion of blood screening programs, advancements in laboratory infrastructure, the growing application of enzyme immunoassays in food safety testing, and the rising demand for veterinary diagnostics.

The enzyme immunoassay market size is expected to see strong growth in the next few years. It will grow to $28.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to government and NGO-driven disease control initiatives, the emergence of autoimmune disease detection, increased adoption of point-of-care testing, rising demand for companion diagnostics in oncology, and a growing geriatric population. Key trends anticipated during this period include technological advancements in microplate readers and reagents, the introduction of innovative diagnostic technologies, development of environmentally friendly reagents, integration of AI and automation into immunoassay processes, and an increase in strategic collaborations and partnerships.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the enzyme immunoassay market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted between individuals. The burden of these diseases is growing due to rising antimicrobial resistance, which complicates treatment, extends recovery times, raises healthcare costs, and leads to increased mortality. Enzyme immunoassays are essential tools for diagnosing infectious diseases, offering sensitive and specific detection of antigens or antibodies in patient samples. This facilitates early diagnosis, effective monitoring, and timely treatment for conditions such as HIV, hepatitis, and influenza. For example, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, reflecting a significant rise in this demographic. As a result, the increasing burden of infectious diseases is contributing to the expansion of the enzyme immunoassay market.

Leading companies in the enzyme immunoassay market are prioritizing the development of advanced solutions, such as fully automated enzyme immunoassays, to boost diagnostic accuracy, reduce human error, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays streamline the entire testing process, enhancing the speed, precision, and reliability of laboratory diagnostics. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), expanding its neuro-biomarker product line. This chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) levels in human plasma and serum using the LUMIPULSE G platform, delivering results within 35 minutes. GFAP is an astrocytic biomarker associated with neurological conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, stroke, and traumatic brain injury. This new assay complements Fujirebio's neurodegenerative disease portfolio, which already includes markers like NfL, pTau217, and sTREM2, supporting comprehensive profiling on a single automated platform.

In January 2025, Medix Biochemica, a Finland-based supplier of raw materials for in vitro diagnostics, acquired CANDOR Bioscience GmbH for an undisclosed sum. This acquisition is aimed at strengthening Medix Biochemica's position as a leading global provider in the IVD industry by expanding its portfolio with CANDOR's specialized expertise in high-performance blockers and assay optimization reagents. These technologies support improved performance in enzyme immunoassays and enable more robust diagnostic test development. CANDOR Bioscience GmbH is a Germany-based biotechnology company that focuses on optimizing immunoassay systems, including enzyme immunoassays and ELISA development.

Major players in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, and Calbiotech Inc.

North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enzyme immunoassay report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enzyme immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme immunoassay market consists of sales of enzyme-labeled antibodies, sample diluents, blocking reagents, microplate readers, ELISA test kits, robotic liquid handling systems, and plate washers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
  • 2) By Specimen: Blood; Saliva; Urine; Other Specimens
  • 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
  • 4) By End-Use: Hospitals; Blood Banks; Clinical Laboratories; Pharmaceutical And Biotech Companies; Academic Research Centers; Other End-Uses
  • Subsegments:
  • 1) By Reagents And Kits: Antibodies; Antigens; Substrates; Buffers And Stabilizers
  • 2) By Analyzers Or Instruments: Fully Automated EIA Analyzers; Semi-Automated EIA Systems; Microplate Readers; Washers And Incubators
  • 3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information System Integration Tools; Instrument Calibration And Validation Services; Technical Support And User Training
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG; Becton Dickinson and Company (BD); PerkinElmer Inc.; BioMerieux SA; Bio-Rad Laboratories Inc.; Diasorin S.p.A.; Bio-Techne Corporation; Quidel Corporation; Promega Corporation; Abcam plc; BioLegend Inc.; Helena Laboratories Corporation; Cayman Chemical Company; Enzo Life Sciences Inc.; RayBiotech Inc.; MyBioSource Inc.; Boster Biological Technology; Hycult Biotech; Calbiotech Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme Immunoassay Market Characteristics

3. Enzyme Immunoassay Market Trends And Strategies

4. Enzyme Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Enzyme Immunoassay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Enzyme Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Enzyme Immunoassay Market Growth Rate Analysis
  • 5.4. Global Enzyme Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Enzyme Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Enzyme Immunoassay Total Addressable Market (TAM)

6. Enzyme Immunoassay Market Segmentation

  • 6.1. Global Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Analyzers Or Instruments
  • Software And Services
  • 6.2. Global Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Saliva
  • Urine
  • Other Specimens
  • 6.3. Global Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Other Applications
  • 6.4. Global Enzyme Immunoassay Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical And Biotech Companies
  • Academic Research Centers
  • Other End-Uses
  • 6.5. Global Enzyme Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibodies
  • Antigens
  • Substrates
  • Buffers And Stabilizers
  • 6.6. Global Enzyme Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fully Automated EIA Analyzers
  • Semi-Automated EIA Systems
  • Microplate Readers
  • Washers And Incubators
  • 6.7. Global Enzyme Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis And Interpretation Software
  • Laboratory Information System Integration Tools
  • Instrument Calibration And Validation Services
  • Technical Support And User Training

7. Enzyme Immunoassay Market Regional And Country Analysis

  • 7.1. Global Enzyme Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Enzyme Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzyme Immunoassay Market

  • 8.1. Asia-Pacific Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzyme Immunoassay Market

  • 9.1. China Enzyme Immunoassay Market Overview
  • 9.2. China Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzyme Immunoassay Market

  • 10.1. India Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzyme Immunoassay Market

  • 11.1. Japan Enzyme Immunoassay Market Overview
  • 11.2. Japan Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzyme Immunoassay Market

  • 12.1. Australia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzyme Immunoassay Market

  • 13.1. Indonesia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzyme Immunoassay Market

  • 14.1. South Korea Enzyme Immunoassay Market Overview
  • 14.2. South Korea Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzyme Immunoassay Market

  • 15.1. Western Europe Enzyme Immunoassay Market Overview
  • 15.2. Western Europe Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzyme Immunoassay Market

  • 16.1. UK Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzyme Immunoassay Market

  • 17.1. Germany Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzyme Immunoassay Market

  • 18.1. France Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzyme Immunoassay Market

  • 19.1. Italy Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzyme Immunoassay Market

  • 20.1. Spain Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzyme Immunoassay Market

  • 21.1. Eastern Europe Enzyme Immunoassay Market Overview
  • 21.2. Eastern Europe Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzyme Immunoassay Market

  • 22.1. Russia Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzyme Immunoassay Market

  • 23.1. North America Enzyme Immunoassay Market Overview
  • 23.2. North America Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzyme Immunoassay Market

  • 24.1. USA Enzyme Immunoassay Market Overview
  • 24.2. USA Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzyme Immunoassay Market

  • 25.1. Canada Enzyme Immunoassay Market Overview
  • 25.2. Canada Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzyme Immunoassay Market

  • 26.1. South America Enzyme Immunoassay Market Overview
  • 26.2. South America Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzyme Immunoassay Market

  • 27.1. Brazil Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzyme Immunoassay Market

  • 28.1. Middle East Enzyme Immunoassay Market Overview
  • 28.2. Middle East Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzyme Immunoassay Market

  • 29.1. Africa Enzyme Immunoassay Market Overview
  • 29.2. Africa Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzyme Immunoassay Market Competitive Landscape And Company Profiles

  • 30.1. Enzyme Immunoassay Market Competitive Landscape
  • 30.2. Enzyme Immunoassay Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Enzyme Immunoassay Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Becton Dickinson and Company (BD)
  • 31.3. PerkinElmer Inc.
  • 31.4. BioMerieux SA
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Diasorin S.p.A.
  • 31.7. Bio-Techne Corporation
  • 31.8. Quidel Corporation
  • 31.9. Promega Corporation
  • 31.10. Abcam plc
  • 31.11. BioLegend Inc.
  • 31.12. Helena Laboratories Corporation
  • 31.13. Cayman Chemical Company
  • 31.14. Enzo Life Sciences Inc.
  • 31.15. RayBiotech Inc.

32. Global Enzyme Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzyme Immunoassay Market

34. Recent Developments In The Enzyme Immunoassay Market

35. Enzyme Immunoassay Market High Potential Countries, Segments and Strategies

  • 35.1 Enzyme Immunoassay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Enzyme Immunoassay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Enzyme Immunoassay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer